(vianews) - shares of neurones (cac 40: nro.pa) dropped by a staggering 10.11% to €36.00 at 10:07 est on wednesday, after four successive sessions in a row of losses. cac 40 is falling 0.74% to €7,088.75, following the last session's upward trend. this seems, up to now, a somewhat bearish trend exchanging session today.
neurones's last close was €40.05, 8.98% under its 52-week high of €44.00.
about neurones
neurones s.a., an information technology (it) services company, provides infrastructure, application, and consulting services in france and internationally. its infrastructure services include infrastructure management, clouds, user support, devops, cybersecurity, it service management, information system governance, and automation. the company also provides application services in the areas of sap integration and outsourcing; mobility, data, iot, digital, agile, ux/ui, and devops; it consulting for finance, big data, ai and blockchain; content management, business process management, paperless process; and it training and working with change management. in addition, it offers consulting services, including management and digital transformation, and digital marketing consulting; digital transformation services in the areas of agile/scrum, devops, ci/cd, cloud, infrastructure as code, cyber security, analytics, big data, mobility, digital workplace, connected devices, innovations, client experience, ux/ui, and digital marketing, as well as internal process digitization, ecm/bpm, rpa, dematerialization, ai, predictive maintenance, machine learning, and blockchain; and managed services/outsourcing services. the company serves banking/insurance, services/consumer goods, energy/utilities/healthcare, technologies/media/telecoms, industry/public works and civil engineering, and public sector markets. neurones s.a. was founded in 1984 and is headquartered in nanterre, france.
earnings per share
as for profitability, neurones has a trailing twelve months eps of €1.27.
pe ratio
neurones has a trailing twelve months price to earnings ratio of 28.35. meaning, the purchaser of the share is investing €28.35 for every euro of annual earnings.
revenue growth
year-on-year quarterly revenue growth grew by 16.4%, now sitting on 665.4m for the twelve trailing months.
more news about neurones (nro.pa).